• 1-800-880-6491

Health Technology

Healthcare technology companies partner with MCI to elevate their profile within the investment community and achieve their capital markets objectives.

Contact UsSubscribe
Investor Sentiment Snapshot

Health Technology

Investor Sentiment Analysis

Health Technology

With few exceptions, the Healthcare Technology space has significantly outperformed the Healthcare Equipment index, the Healthcare Services index, and the S&P 500. This is especially true of roll-up plays such as Vitalhub.

Investors in the health technology sector are increasingly favoring digital services models with a strong recurring revenue base that improve access to care, patient outcomes, and system efficiency. While capital continues to flow into digital health platforms, AI-driven diagnostics, and tech-enabled care delivery, investors in companies with active M&A strategies are closely monitoring value accretion, integration success / synergy achievement, organic growth, and profitability. Institutional investors are prioritizing scalability.  For Canadian firms, alignment with national health system goals and cost-effectiveness is essential to investor appeal.

The Health Technology Sector's

Challenges

Health services and technology companies face a complex set of structural and macro challenges:

  • Cybersecurity in an environment of increasing attacks on sensitive systems and data
  • Regulatory hurdles with respect to patient privacy and digital health implementations
  • Workforce shortages and burnout driving inefficiencies across service models
  • High investor skepticism toward overly niche solutions
  • Integration challenges including key employee retention while achieving acquisition synergies
The Health Technology Sector's

Opportunities

Despite challenges, the industry offers significant growth potential for companies positioned around transformation and efficiency:

  • Demand surge for virtual care, remote monitoring, and value-based care platforms
  • Strategic M&A interest from payers, providers, and tech giants seeking platform assets
  • AI-driven automation of diagnostics, care coordination, and clinical decision support
  • Government incentives and policies supporting digital transformation in healthcare
  • Strong appetite for integrated, cloud-based solutions across the care continuum
Implications for your

Investor Relations & Capital Markets Strategy

Effective health technology investor relations in 2025 demands a nuanced understanding of both capital markets and healthcare delivery transformation. IR teams must align messaging with investor priorities around scalable business models, strong customer relationships, and positive outcomes. Given increasing investor scrutiny related to revenue predictability and the path to value creation, companies must articulate how their solutions integrate within existing systems, reduce the cost of care, and drive measurable value.

Capital markets strategy should emphasize commercial traction and customer retention metrics. For Canadian companies, highlighting alignment with provincial and federal health modernization goals can strengthen cross-border investor interest. Firms must be prepared to discuss the regulatory environment proactively and in detail  particularly with respect to privacy, AI in diagnostics, and virtual care.

Investors also expect transparency around data use, security protocols, and ESG practices, particularly as healthcare becomes more digital. M&A positioning should be framed around ecosystem integration, defensibility, and strategic moats rather than scale alone. IR and management teams must also be sensitive to the concerns of incoming employees for companies with active M&A programs to avoid retention issues. IR should use investor days, whitepapers, and earnings materials to reinforce a consistent value creation strategy, replicable acquisition and integration models, effective leadership, strong customer relationships, and long-term vision. In this evolving market, clear, credible, and consistent communication will differentiate the winners.

Our Capabilities
MCI Capabilities

Activist Resolution

MCI Capabilities

Corporate Communications

MCI Capabilities

Capital Markets
Strategy

MCI Capabilities

Crisis
Communications

MCI Capabilities

Debt and Equity
Offerings

MCI Capabilities

Financial
Reporting

MCI Capabilities

Design &
Branding

MCI Capabilities

Digital
Technologies

MCI Capabilities

ESG &
Sustainability

MCI Capabilities

Investor Perception
Studies

MCI Capabilities

Initial Public
Offerings

MCI Capabilities

Ongoing Investor
Relations

MCI Capabilities

Investment
Grade Events

MCI Capabilities

Market
Coaching

MCI Capabilities

Market
Connect

MCI Capabilities

Market
Turnaround

MCI Capabilities

Transaction
Communications

Learn more about the capital markets

Access Our Insights

Broker-Dealer Relationships – Building a Marriage of Equals

 Broker-Dealer Relationships – Building a Marriage of Equals 1024 576 MCI Capital Markets

Choosing the right broker-dealers to work with is nearly as important as choosing who to marry. The right partner will support you – the wrong partner will leave you on the sidelines. Companies must partner with firms whose capabilities, sector focus, and size align with the company’s own. In short, companies should seek a marriage of equals when it comes to the sell side.

Share buybacks, NCIBs, and repurchases can hurt your company's share performance

The Hidden Dangers of Share Buybacks and NCIBs

 The Hidden Dangers of Share Buybacks and NCIBs 1024 576 MCI Capital Markets

Share buybacks often look like a winning strategy. They boost EPS, return cash, and signal confidence. But for companies with small floats or weak liquidity, buybacks can seriously undermine value. This post explains why, and offers a checklist for boards to consider before repurchasing shares.

Artificial Intelligence Can Hurt IR

Artificial Intelligence: How It Can Help and Hurt Investor Engagement

 Artificial Intelligence: How It Can Help and Hurt Investor Engagement 1024 576 MCI Capital Markets

AI tools like chatbots and outreach agents promise efficiency for IR teams. But if they reduce human contact, they can hurt your investor conversion funnel. This post shows when AI helps — and when it harms investor engagement — and offers practical guardrails for IR professionals.

Renegade Board

Renegade Boards: When Directors Go Rogue

 Renegade Boards: When Directors Go Rogue 1024 576 MCI Capital Markets

Renegade boards can disrupt strategy, destroy value, and blindside shareholders. This post explains why boards go rogue, highlights real cases like Gildan and Nestlé, and shows how management can protect the company through stronger investor relationships, clearer communication, and smarter governance practices.

Hostile Market Actors

Hostile Market Actors: Putting Management in the Crosshairs

 Hostile Market Actors: Putting Management in the Crosshairs 1024 576 MCI Capital Markets

Public companies that have been trading at a durable discount for a protracted period face serious risks from hostile market actors. Activist investors, opportunistic takeover bids, and renegade boards can challenge management, disrupt strategy, or force governance upheaval.

Reach New Institutional Investors

Reach New Institutional Investors

 Reach New Institutional Investors 1024 576 MCI Capital Markets

Public companies face real challenges in reaching new institutional investors. Broker led corporate access prioritizes commission payers, which may not be the investors best suited for the company. To break through, companies must take control of institutional investor targeting.

The Three Pillars of Quantitative Investor Targeting

Quantitative Investor Targeting Relies on Three Pillars

 Quantitative Investor Targeting Relies on Three Pillars 1024 576 MCI Capital Markets

Accurate quantitative investor targeting depends on three pillars: clean and current ownership data, comprehensive fundamental financial data, and a rigorously back-tested targeting model. When any one of these elements is weak, targeting accuracy drops, and IR teams risk wasting time on irrelevant outreach.

The importance of an Investor Relationship Management Systems

No Investor Relationship Management System = No IR Program

 No Investor Relationship Management System = No IR Program 1024 576 MCI Capital Markets

In today’s capital markets no capability is more fundamental to a modern investor relations (IR) function than an effective Investor Relationship Management (IRM) system. The IRM is not “nice to have.” It should be at the operational core of every IR program.

apply an investor conversion funnel to turn anonymous analysts, media and non-investors into engaged participants

Deploying a Sound Investor Conversion Funnel

 Deploying a Sound Investor Conversion Funnel 1024 576 MCI Capital Markets

A functional investor conversion funnel is required for a fully integrated strategic investor relations program. Yet so many companies fail to capture and curate their key relationships in the capital markets to the detriment of shareholder value.

Contact Us

The capital markets can be bewildering, even to the most experienced management teams. We believe that most executives are committed to maximizing shareholder value, but poorly executed investor relations can lead to valuation loss, reputational damage, employee attrition, deal failure, and even shareholder revolt.

MCI has helped its clients unlock billions of dollars in market value through a proven system that delivers sound messaging, branding, and engagement strategies. Over the past two decades our team has been involved in $5.7 billion in corporate actions that include $3.1 billion in acquisitions and $2.6 billion in financings-all successful.

MCI can help you resolve unfair valuation discounts and get the most out of your company’s public listing. Contact us today to engage our data driven, results focused process to unleash real progress.